CD8+ T cells are an in vivo reservoir for human T-cell lymphotropic virus type I

Blood

Volumn 98, Issue 6, 2001, Pages 1858-1861

  Nagai, Masahiro ^a   Brennan, Meghan B ^a   Sakai, Jill A ^a   Mora, Carlos A ^a   Jacobson, Steven ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; TAX PROTEIN; VIRUS DNA;

ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS CULTURE; VIRUS INFECTION; VIRUS ISOLATION; VIRUS LOAD;

EID: 0035885960     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.6.1858     Document Type: Article

References (40)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77:7415-7419.
2. Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220:868-871.
3. Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984;224:500-503.
4. Popovic M, Lange-Wantzin G, Sarin PS, et al. Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus. Proc Natl Acad Sci U S A. 1983;80:5402-5406.
5. Popovic M, Read-Connole E, Gallo RC. T4 positive human neoplastic cell lines susceptible to and permissive for HTLV-III [letter]. Lancet. 1984;2:1472-1473.
6. Dalgleish AG, Beverley PC, Clapham PR, et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 1984;312:763-767.
7. Klatzmann D, Champagne E, Chamaret S, et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature. 1984;312:767-768.
8. Uchiyama T, Yodoi J, Sagawa K, et al. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481-492.
9. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985;2:407-410.
10. Osame M, Izumo S, Igata A, et al. Blood transfusion and HTLV-I associated myelopathy [letter]. Lancet. 1986;2:104-105.
11. Nishioka K, Maruyama I, Sato K, et al. Chronic inflammatory arthropathy associated with HTLV-I [letter]. Lancet. 1989;1:441.
12. Sugimoto M, Nakashima H, Watanabe S, et al. T-lymphocyte alveolitis in HTLV-I-associated myelopathy [letter]. Lancet. 1987;2:1220.
13. Morgan OS, Rodgers-Johnson P, Mora C, Char G. HTLV-1 and polymyositis in Jamaica. Lancet. 1989;2:1184-1187.
14. Ohba N, Matsumoto M, Sameshima M, et al. Ocular manifestations in patients infected with human T-lymphotropic virus type I. Jpn J Ophthalmol. 1989;33:1-12.
15. Trejo SR, Ratner L. The HTLV receptor is a widely expressed protein. Virology. 2000;268:41-48.
16. Ho DD, Rota TR, Hirsch MS. Infection of human endothelial cells by human T-lymphotropic virus type I. Proc Natl Acad Sci U S A. 1984;81:7588-7590.
17. Yoshikura H, Nishida J, Yoshida M, et al. Isolation of HTLV derived from Japanese adult T-cell leukemia patients in human diploid fibroblast strain IMR90 and the biological characters of the infected cells. Int J Cancer. 1984;33:745-749.
18. Richardson JH, Edwards AJ, Cruickshank JK, et al. In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol. 1990;64:5682-5687.
19. Hattori T, Uchiyama T, Toibana T, et al. Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies. Blood. 1981;58:645-647.
20. Tanaka A, Takahashi C, Yamaoka S, et al. Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proc Natl Acad Sci U S A. 1990;87:1071-1075.
21. Jacobson S, Zaninovic V, Mora C, et al. Immunological findings in neurological diseases associated with antibodies to HTLV-I: activated lymphocytes in tropical spastic paraparesis. Ann Neurol. 1988;23:S196-S200.
22. Tendler CL, Greenberg SJ, Blattner WA, et al. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proc Natl Acad Sci U S A. 1990;87:5218-5222.
23. Koyanagi Y, Itoyama Y, Nakamura N, et al. In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology. 1993;196:25-33.
24. Cho I, Sugimoto M, Mita S, et al. In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1 -associated myelopathy/tropical spastic paraparesis. Am J Trop Med Hyg. 1995;53:412-418.
25. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res. 1996;6:986-994.
26. + T-cells. Blood. 2001. In press.
27. Nagai M, Usuku K, Matsumoto W, et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol. 1998;4:586-593.
28. - T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood. 2000;95:1386-1392.
29. Kinoshita T, Shimoyama M, Tobinai K, et al. Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc Natl Acad Sci U S A. 1989;86:5620-5624.
30. + T cells. Science. 1995;270:1811-1815.
31. Pal R, Garzino-Demo A, Markham PD, et al. Inhibition of HIV-1 infection by the beta-chemokine MDC. Science. 1997;278:695-698.
32. Hanon E, Stinchcombe JC, Saito M, et al. Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity. 2000;13:657-664.
33. Wang TG, Ye J, Lairmore MD, Green PL. In vitro cellular tropism of human T cell leukemia virus type 2. AIDS Res Hum Retroviruses. 2000;16:1661-1668.
34. + cells in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load. J Infect Dis. 2001;183:197-205.
35. Jacobson S. Human T lymphotropic virus, type-I myelopathy: an immunopathologically mediated chronic progressive disease of the central nervous system. Curr Opin Neurol. 1995;8:179-183.
36. Bangham CR. The immune response to HTLV-I. Curr Opin Immunol. 2000;12:397-402.
37. Koenig S, Woods RM, Brewah YA, et al. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease. J Immunol. 1993;151:3874-3883.
38. Ijichi S, Izumo S, Eiraku N, et al. An autoaggressive process against bystander tissues in HTLV-I-infected individuals: a possible pathomechanism of HAM/TSP. Med Hypotheses. 1993;41:542-547.
39. Azimi N, Brown K, Bamford RN, et al. Human T cell lymphotropic virus type I Tax protein transactivates interleukin 15 gene transcription through an NF-kappaB site. Proc Natl Acad Sci U S A. 1998;95:2452-2457.
40. + memory T cells by opposing cytokines. Science. 2000;288:675-678.